This hypothesis paper examines whether excessive zinc supplementation during pregnancy could disrupt fetal copper metabolism sufficiently to precipitate Menkes disease, a rare X-linked disorder of copper transport. The authors review the mechanistic basis of zinc-copper antagonism via metallothionein induction, synthesize RCT evidence on zinc supplementation in pregnancy, and document dietary copper sources and the zinc tolerable upper intake level.
Key numbers
- Zinc tolerable upper intake level: 40 mg/day for adults (p. 1).
- Zinc recommended dietary allowance: 11 mg/day for adult men; 8 mg/day for adult women (p. 1).
- Copper recommended dietary allowance: 900 µg/day for adults; 1,000 µg/day during pregnancy; 1,300 µg/day during lactation (p. 2).
- Copper food sources: oysters 44,996 µg per 100 g; beef liver 6,434 µg per 100 g; cocoa approximately 5,000 µg per 100 g (p. 2).
- Zinc-induced copper deficiency mechanism: at 150 mg/day elemental zinc for 6 weeks, significant declines in serum copper and ceruloplasmin activity were observed (p. 3).
- Meta-analysis finding (16 RCTs): zinc supplementation in pregnancy associated with 14% reduction in preterm births (no other significant maternal or neonatal benefits) (p. 4).
- Majority of trials in meta-analysis administered 20 to 30 mg of zinc predominantly as zinc sulfate (p. 4).
- Metallothionein affinity: copper has a higher binding affinity for metallothionein than zinc; excess zinc induces intestinal metallothionein, which preferentially sequesters copper in enterocytes, reducing copper absorption (p. 3).
Methods (brief)
Narrative hypothesis paper drawing on published RCTs, meta-analyses, and mechanistic literature. No primary data collection. LOD/LOQ, CRM, and recovery data are not reported (not applicable to this document type). The hypothesis is not empirically tested within the paper itself.
Evidence fitness
This source supports characterization of the zinc-copper antagonism mechanism (metallothionein induction), the zinc tolerable upper intake level, recommended dietary allowances for zinc and copper, copper dietary food sources (oysters, liver, cocoa), and RCT-level evidence on zinc supplementation outcomes in pregnancy. It does not provide food concentration data for finished food products beyond the named commodity-level copper values, and it does not provide epidemiological data for the Menkes disease-zinc supplementation hypothesis (the hypothesis is not yet tested in humans).
Limitations
Hypothesis paper only; the central claim (that zinc supplementation during pregnancy can cause Menkes disease) is not supported by clinical or epidemiological evidence reviewed in the paper. The meta-analysis of 16 RCTs cited is a secondary synthesis; the primary RCTs are not individually reviewed. LOD/LOQ and analytical method data are not reported for the copper food concentration values cited (derived from USDA or similar databases, not from independent analytical measurement by the authors).
Related evidence
Update history
No substantive edit history is available in this build. The full commit record is available in git.